AMSTERDAM, The Netherlands, June 6, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced results for the first quarter of 2014. As of March 31, 2014, the Company held cash and cash equivalents of €77.5 million.
Help employers find you! Check out all the jobs and post your resume.
